Home › Biotechnology

Biotechnology Market Research Reports & Consulting

Market Reports

Title	Published	Price
European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017 The Europeandrug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery.	June 2013	$ 4650
Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017 Patent expiry of major blockbuster drugs is a foremost concern for pharmaceutical companies. Developing a new chemical entity (NCE) is more expensive and time consuming than developing a novel drug delivery technology. Therefore, in recent years many pharmaceutical companies have employed drug delivery technology as a life cycle management tool for some of their blockbuster drugs, the patents for which are set to expire in near future.	April 2013	$ 4650
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017 The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.	April 2013	$ 4650
Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017 Globally, injectable medications form the second most preferred class of drugs, with oral route of administration leading the global pharma market. Injectable drug delivery devices have evolved from traditional needles and syringes to recently developed needle-free injectors. The market has evidenced a shifting trend from administration of injections in clinician settings to home care settings, which has resulted in increasing the focus of industry players towards the development of user friendly and patient compliant devices.	April 2013	$ 4650
Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] – Global Forecasts to 2017 A biomaterial is a natural or synthetic material suited to replace or treat natural body tissues and organs on interaction with biological systems. It traces its history to more than 2000 years ago, when Romans, Chinese, and Aztecs used gold for dental applications. Biomaterials, which are also biocompatible, have since been adapted, improvised, and technically enabled to improve body functions and replace damaged tissues. They have evolved to include biodegradable materials that are easily dissolved in the body. Advances in technology and the emergence of innovative biomaterial products have enhanced their performance and applications.	March 2013	$ 4650
Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017 Proteins exhibit high specificity and less immunogenicity and are widely used as therapeutic agents in the treatment of various disorders and diseases. There are more than 200 protein-based products currently being marketed; 90% of them are used as therapeutics. In order to improve their clinical potential, second generation recombinants are being developed, each exhibiting improved efficiency and potency depending on their applications.	March 2013	$ 4650
Global Transfection Technologies Market (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) And Types (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) (2012 – 2017) Transfection is an enabler technology used for many cell based research activities with applications spanning production of recombinant proteins and recombinant cell lines, gene therapy, delivery of therapeutics and also drug discovery. This research report provides a brief description on transfection technologies, its evolution, comparative analysis, market landscape analysis, competitive scenario and emerging technology and application trends.	December 2012	$ 4650
Global Biobank (Biospecimen/ Biorepository/Biopreservation) Market for Equipment and Media - Trends and Forecast to 2017 Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. Cryopreservation, vitrification and hypothermic storage are the common biopreservation procedures used widely in laboratory and clinical settings. The increase in cell-banking systems like adult stem cell banking, tissue banking, and umbilical cord blood banking has led to an increase in demand for the concept of biopreservation. Antibodies and proteins obtained from high-yielding cell-lines are required by biotech and pharmaceutical companies for research, diagnostic or clinical purposes. These high-yielding cell lines need to be preserved to give optimum yield, viability and productivity.	October 2012	$ 4650
Proteomics Market (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Trends & Global Forecasts to 2017 Proteomics, over the last decade, has gained importance in the field of diagnosis and drug research and development. It has various applications, ranging from identifying proteins and performing a protein expression profile by identifying the protein in a specific state of an organism to analyzing the interaction of proteins in living organisms. It also helps to map the modifications of proteins. Thus, it is evolving into an important tool in the field of life sciences.	October 2012	$ 4650
Biotechnology Reagents Market by Technology, Applications and End-Users - Current Trends, Opportunities and Global Forecasts to 2016 Biotechnology reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading. These reagents are used in the field of research, diagnosis, bioscience, and education.	July 2012	$ 4650
Life Sciences & Analytical Reagents Market - Applications, Current Trends, Opportunities & Global Forecasts (2011 – 2016) The life sciences and analytical reagents market report studies the life science and analytical reagents market, by technology, end-users, and applications. The life sciences and analytical reagents market, by technology studied in this report are segmented as life science reagents and analytical reagents; of which life science segment accounted for the largest share of 59.37% of the total market in 2011.	May 2012	$ 4650
Ablation Technologies Market (2011-2016) - (Cancer/tumor, Cardiac, Gynecology, Orthopedics, Radiofrequency, Cryoablation, Microwave, Hydrothermal, Radiation and Laser/ Light) - Global Trends & Competitive Analysis The global ablation technologies market consists of thermal and non- thermal ablation technologies. Under thermal ablation technologies, radiofrequency, microwave, ultrasound, hydrothermal, radiation, electrical and light/laser technologies are included, whereas non-thermal ablation technologies include cryoablation and hydromechanical. Ablation technologies have applications in various clinical areas such as cancer, cardiac, ophthalmology, urology, gynecology and orthopedics.	May 2012	$ 4650
Life Science and Chemical Instrumentation Market (2011 - 2016) (Spectroscopy, Chromatography, DNA Sequencer & Amplifier, Lab Automation, Array, Flow Cytometer, Electrophoresis, Immuno Assay & Others) Global Trends, End User & Competitive Analysis Life science and chemical equipment market is growing at a rapid rate due to the continuous requirement of these instruments in pharmaceutical and biotechnology industries. Besides, the increase in number of biotechnology firms worldwide, advances in life science research and technology innovations with human genome mapping, and emergence of proteomics have enabled industry growth; as such high-end research projects require quality instruments with high throughput capacity. All these factors are driving the life science and chemical instrumentation market.	February 2012	$ 4650
Biomarkers Market Discovery Technologies (Proteomics, Genomics, Imaging, Bioinformatics), Applications (Drug Discovery, Personalized Medicine, Molecular Diagnostics) & Indications (Cancer, Cardiovascular & Neural) - Global Trends & Forecasts (2011 – 2020) A biomarker is defined as a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic response to a therapeutic intervention. Biomarkers are classified in different ways based on different parameters such as on the basis of their application, their characteristics and on their usage in decision making in early drug development. With drug development facing challenges from ever increasing cost of developing drugs and rise in the failure rate for drugs in phase II and III clinical trials, biomarkers are being employed on large scale by pharmaceutical companies to overcome these challenges. Also the advent of personalized medicine and companion diagnostics is witnessing a strong presence of use of biomarkers and holds to be a big opportunity for the overall biomarker market.	January 2012	$ 4650
Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015) The report analyzes the various product segments under the broader biochips market, including lab chips, DNA chips etc. Market analysis includes over 100 market data tables that examine the biochips industry by products and geographies. The report has also profiles the key players and the competitive landscape in detail.	August 2011	$ 4650
Global DNA and Gene Chip (Microarrays) Market (2010 – 2015) The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010.	May 2011	$ 4650
Brazil Biomaterials Market (2010-2015) Brazil Biomaterials Market is expected to reach $1.7 billion in 2015 from $550.2 million in 2008 with a CAGR of 19.5% from 2010 to 2015. In 2009, the orthopedic biomaterial market recorded revenues of $236.5 million or 37.5% of the total biomaterial products market. This is mainly because of increasing application areas and introduction of sophisticated technologies in the biomaterials market. However, the orthopedic biomaterial market is estimated to grow at a CAGR of 17.2% from 2010 to 2015. Cardiovascular biomaterial products market is the second-highest market, contributing 36% of the total biomaterial products market.	May 2011	$ 4650
Top 10 Drug Delivery Technologies Market (Topical, Oral Time Release/Sustained Release, Targeted Delivery, Encapsulation, Aerosol/Inhalation, Transdermal, Implants, Injectable, Liposomal, Pegylation) - Global Trends, Challenges & Forecasts up till 2015 This report provides industry analysis, competitive landscape and in-depth market segmentation for all the top 10 drug delivery technologies. It provides market data for the oral delivery system, which still dominates the drug delivery market. In addition, the report also analyzes the market data on emerging drug delivery technologies like needleless injectables, PEGylation technologies and microelectromechanical devices.	February 2011	$ 4650
Strategic Analysis & Forecast of US Biopharmaceutical Industry (2009-2016): Impact of Healthcare Reform, Technological Innovation & Market The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. The growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S. market revenues are forecasted to grow at a compound annual growth rate (CAGR) of 11.2%.	February 2011	$ 4650
Top 10 Drug Discovery Technologies Market – Strategic Analysis and Global Forecasts (2010 to 2015) The top 10 drug discovery technologies play a vital role in the growth of the entire pharmaceutical industry as they are the key contributors in the swift introduction of blockbusters and innovative drugs, which is the most important aspect for the pharmaceutical companies.	November 2010	$ 4650
Global Stem Cell and Advanced Technologies Market This report reviews the current technologies in stem cell research and records the advances made in the development of these technologies and tools. The report gives a 360° view of the stem cell research market through its exhaustive market data on geographies, key players and technologies. Key players are profiled along with an analysis of their market strategies.	November 2009	$ 4650
Biosimilars (2009 - 2014) Biosimilars report will provide indepth market assessment, market estimates and forecast, competitive landscape for the series of biosimilars- Erythropoeitins, Granulocyte Colony Stimulating Factors, Market, HGH, Insulin and Analogs, Interferons. Report code- LS00110	September 2009	$ 4650

Title	Published	Price
Global Genomics Market (2012 – 2017) Genomics is a discipline in genetics concerned with the study of the genomes of organisms. The field includes efforts to determine the entire DNA sequence of organisms and fine-scale genetic mapping.	August 2013	$ 4650
Cell Culture Market for Media, Sera and Reagents (2012 - 2017) The choice of cells depends on various technical and economic aspects. E. coli, Bacillus subtitlus, and yeast are the most preferred bacteria as they are easier to grow, independent, and have metabolic capabilities. On the other hand, animal cells are fragile, larger than microorganisms and difficult to grow. Another important driver is the development of vaccines; influenza vaccines have been previously developed with the help of egg-based technology. However, due its labor-intensive approach, this has been replaced with cell culture. A growth in this market will subsequently drive the market for cell culture.	August 2013	$ 4650
Electrophoresis Market (2011-2016) Electrophoresis is known as one of the most frequently used separation and analysis technologies in life science laboratories. The electrophoresis market is segmented in to two major segments gel electrophoresis (GE) and capillary electrophoresis (CE) of which gel electrophoresis accounts for the largest share of this market. This segment is expected to register a modest growth of around 4% primarily due to high installed base of these systems. Genomics, one of the primary applications is fueling the growth of this market.	August 2013	$ 4650
Global Vital Signs Monitoring Devices Market (2013-2018) The word “vital” connotes the most significant requirement for sustaining healthy life. Blood pressure, respiratory rate, heart rate and body temperature within a normal range are necessary for the survival of human life and these parameters are referred to as vital signs.	August 2013	$ 4650
Sequencers & Synthesizers Market: Global Forecasts (2011-2016) The global sequencers and synthesizers market comprises on DNA sequencers, amino acid sequencers and protein/peptide sequencers and synthesizers. The DNA sequencing market, the largest contributing segment is expected to have high growth of about 20% during the study period. Life Science, drug discovery & development account for the two largest applications market in the DNA sequencing market. Emerging applications for DNA sequencing include clinical diagnostics and personal genomics.	August 2013	$ 4650
Mass Spectrometry Market: Global Forecasts (2011-2016) The mass spectrometry market has evolved from basic research in the early 20th century to a host of applications consisting of pharmaceutical development, cancer research, petroleum refining & security and monitoring. Development of improved ionization sources increased the applicability of the instruments. Pharmaceuticals, proteomics, biomarker research form the largest market for Mass Spectrometry, however, environmental testing, petroleum refining, security and semiconductor & electronics segments also contribute largely to the market.	August 2013	$ 4650
Immunoassay Market (2011-2016) Immunoassays are most common lab test which help in identifying and quantifying blood components for a particular disease; most test focus on proteins in blood or other samples. Immunoassays are increasing used diagnosing cancer, disease research and immunology and have wide customer base in academic and the industrial arena. Shift in focus from genomics to proteomics is one of the driving factors in the market for immunoassays. Apart from this growth is also fueled by advances in technology which are faster, more accurate and cost effective such as ultrasensitive platforms, multiplex technologies, and novel biomarkers.	August 2013	$ 4650
Aptamers Technology and Market Landscape – Forecasts (2013-2018) Aptamers are relatively short (12-30 base) ssDNA or RNA oligonucleotides (or peptides) that were first described in 1980s, represent promising class of therapeutics. Regardless of rising competition from various small molecules and technologies, the aptamer manufacturers/providers foresee an extraordinary growth. Aptamers, typically generated through Systematic Evolution of Ligands by EXponential enrichment (SELEX) have rapidly emerged as a novel and potent class of ligands with exceptional prospective for diagnostic and therapeutic applications.	August 2013	$ 4650
Dietary Supplements Market: Global Trends, Forecasts & Market Estimates up to 2017 The Global healthcare and mal-nutrition problems are increasing, creating a demand for dietary supplements. These supplements can be consumed as additional dietary supplement by individuals, along with medicines by weak or recovering patients or as sports energy drinks.	August 2013	$ 4650
SNP (Single Nucleotide Polymorphism) Market: Genotyping and Analysis, Future of SNPs in Personalized Medicine (2011-2016) SNP (Single Nucleotide Polymorphism) genotyping is a measurement of genetic variations. It is the most common type of genetic variation between humans. Specific single base pair mutations are ideal for identifying correlation between genotype and human behavior.	August 2013	$ 4650
Next Generation Sequencing (Ngs) Market By Technology (Pyrosequencing & Others), Services, Applications And Tools - Global Trends And Forecasts (2012 - 2017) Next generation sequencing is the next generation of DNA sequencing which includes several technologies to determine the order of nucleotide bases in a molecule of DNA. It is the fastest growing and the most lucrative segment in the genomics space. With estimated double digit growth, next generation sequencing will revolutionize the medical research in academic laboratories, biopharma, and the applied markets.	August 2013	$ 4650
Global Nanobiotechnology Market (2012 - 2017) Nanobiotechnology is that branch of nanotechnology that deals with biological and biochemical applications or uses. Nanobiotechnology often studies existing elements of living organisms and nature to fabricate new nano-devices. Generally, nanobiotechnology refers to the use of nanotechnology to further the goals of biotechnology.	August 2013	$ 4650
Synthetic Biology Market – Products (Synthetic Genes, DNA), Technologies (DNA/Genome sequencing, Bioinformatics, Oligotide synthesis, Annealing), Applications (Energy - Biodiesel, Pharma, Chemicals & Agriculture) Global Trends & Forecasts till 2017 Synthetic biology is a technology that designs biological cells/tissues/genes, devices and systems, and redesign the natural biological systems for various industrial utility. Synthetic biology has broad spectrum of applications across industries like Pharmaceuticals, medicine, diagnostics, energy, chemicals, agriculture and more.	August 2013	$ 4650
Global Biobanking Devices Market (2012 - 2017) The Biobanks market worldwide is characterized by a host of private biobanks, public/government sponsored biobank institutions and research-based biobanks affiliated with universities or research groups. Service providers and suppliers/manufacturers of biobank resources and equipments form an integral part of the supply chain structure.	August 2013	$ 4650
Neuroscience Technologies and Global Market (2012 - 2017) Neuroscience research has come into prominence in the U.S. because of its military applications. Research has indicated that neuroscience can enhance the performance, learning and training of military personnel. This market research report takes an overview of the emerging technologies and tools in this area and also provides market data and profile of the key players.	August 2013	$ 4650
Global RNAi Technology Market (2012 - 2017) The report presents the latest advances in RNAi technologies and their clinical implication as a therapeutic platform. It charts the current trends in RNAi therapeutics, and analyzes the opportunities and challenges faced by the RNAi companies. The focus will be on the clinical needs, patented technologies and the competitive landscape across geographies.	August 2013	$ 4650
Cardiovascular Therapy - Advanced Technologies And Global Market (2012 - 2017) The research report outlines the latest developments in the cardiovascular therapy industry across the globe. The market data includes innovative technologies, key players, market trends and opportunities, drivers and challenges are clearly identified and examined.	August 2013	$ 4650
Global Forensic Technology Market (2012 – 2017) Technology advancements in forensics have been of considerable importance in recent years. Recent examples include improved fingerprint recovery from metals, such as gun cartridges and bomb fragments, use of the chemistry of color to identify chemical and biological weapons, and sensing technologies that are improving the detection of drugs and explosives at security checkpoints.	August 2013	$ 4650
Chromatography Market (Gas Chromatography Market, Liquid Chromatography Market) (2011-2016) The global chromatography market has been segmented into liquid chromatography (LC) and gas chromatography (GC). LC is primarily utilized for commercial applications such as drug development and quality assessment of pharma and biopharma products. Widenning applications are the primary growth driver in this market. Apart from that, the greater efficiency levels offered by LC is another driving factor for this market. On the other hand GC is ruled by Chemicals & Pharmaceuticals end-use sector and forms a major growth driver in this market. Environmental and food safety issues in the developed countries is another major factor driving the market. Europe accounts for the largest share in the GC market, followed by the U.S. and Japan. APAC is expected to register the highest growth.	August 2013	$ 4650
Preimplantation Genetic Diagnosis (PGD) Market - Global Trends, Opportunities, Challenges And Forecasts (2012-2017) Preimplantation genetic diagnosis (PGD) is a prenatal diagnosis technique that diagnoses genetic abnormalities before hand in Assisted Reproductive Technology (ART) procedures. This technique effectively detects chromosomal and single-gene disorders with greater accuracy compared to other genetic testing methods. Improvement in the adoption of In-vitro Fertilization (IVF) technique among the physicians and patient community is opening doors for the growth of PGD market.	August 2013	$ 4650
Nerve Repair and Regeneration Market (2012-2017) - Global Trends, Opportunities and Forecasts to 2017 Nerve repair techniques and products have improved over the last few years, however, some areas such as repairing nerves over 3 cm long still remains challenging. The allograft which had been the traditional standard of treatment involves using a section of healthy nerve (autograft) from another part of the patient's body to bridge the damaged nerve gap.	August 2013	$ 4650